Treatment with UV1 was put on hold (October 2015) in the three UV1 phase I studies due to serious allergic reactions related to high levels of IgE against GM-CSF and UV1, mainly in the prostate cancer study (14). The gene discussed is CSF2; the disease is prostate cancer.